Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease.
Cardiovascular risk factors promote the development of cardiovascular disease by producing endothelial dysfunction. Interventions that improve endothelial function would therefore be expected to help prevent coronary disease. Studies have demonstrated that a variety of interventions, both pharmacological and nonpharmacological, can improve endothelial dysfunction. Several pharmacological interventions are briefly reviewed, with an emphasis on current issues and controversies.
University of Maryland Hospital, Division of Cardiology, Baltimore 21201, USA. rvogel@heart.ab.umd.edu
R
R
Vogel
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology; D006801:Humans
D000806:Angiotensin-Converting Enzyme Inhibitors; D000975:Antioxidants; D002121:Calcium Channel Blockers